Alnylam Pharmaceuticals, Inc. ALNY
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Martin Auster | Raymond James | 398.29 $ | 472 $ | 73.71 % | 12/01/2026 |
| Mani Foroohar | Leerink Partners | 399.4194 $ | 351 $ | -48.42 % | 15/12/2025 |
| Patrick Trucchio | H.C. Wainwright | 434.07 $ | 570 $ | 135.93 % | 04/11/2025 |
| Leland Gershell | Oppenheimer | 449.56 $ | 500 $ | 50.44 % | 31/10/2025 |
| Keay Nakae | Chardan Capital | 449.56 $ | 475 $ | 25.44 % | 31/10/2025 |
| Michael Ulz | Morgan Stanley | 449.56 $ | 495 $ | 45.44 % | 30/10/2025 |
| Michael Ulz | Morgan Stanley | 456.35 $ | 475 $ | 18.65 % | 06/10/2025 |
| Paul Matteis | Stifel Nicolaus | 456.35 $ | 495 $ | 38.65 % | 06/10/2025 |
| Kostas Biliouris | BMO Capital | 452.81 $ | 470 $ | 17.19 % | 05/09/2025 |
| Danielle Brill | Truist Financial | 324.492 $ | 385 $ | 60.51 % | 21/07/2025 |
| Kostas Biliouris | BMO Capital | 325 $ | 360 $ | 35.00 % | 24/06/2025 |
| William Pickering | Bernstein | 235.95 $ | 310 $ | 74.05 % | 07/01/2025 |
| Whitney Ijem | Canaccord Genuity | 294.87 $ | 336 $ | 41.13 % | 24/10/2024 |
| Whitney Ijem | Canaccord Genuity | 273.69 $ | 366 $ | 92.31 % | 01/10/2024 |
| Tazeen Ahmad | Bank of America Securities | 274.91 $ | 307 $ | 32.09 % | 27/09/2024 |
| Kostas Biliouris | BMO Capital | 269.31 $ | 300 $ | 30.69 % | 27/08/2024 |
| Luca Issi | RBC Capital | 271.425 $ | 300 $ | 28.58 % | 26/08/2024 |
| Salveen Richter | Goldman Sachs | 262.7 $ | 370 $ | 107.30 % | 16/08/2024 |
| Whitney Ijem | Canaccord Genuity | 253.86 $ | 357 $ | 103.14 % | 08/07/2024 |
| Esther Rajavelu | UBS | 247 $ | 288 $ | 41.00 % | 28/06/2024 |
| Luca Issi | RBC Capital | 245.17 $ | 265 $ | 19.83 % | 27/06/2024 |
| Paul Matteis | Stifel Nicolaus | 247.3962 $ | 295 $ | 47.60 % | 27/06/2024 |
| Liisa Bayko | Evercore ISI | 222.9 $ | 260 $ | 37.10 % | 25/06/2024 |
| Luca Issi | RBC Capital | 222.9 $ | 250 $ | 27.10 % | 25/06/2024 |
| Andrew Galler | Morgan Stanley | 224.7 $ | 250 $ | 25.30 % | 24/06/2024 |
| Patrick Trucchio | H.C. Wainwright | 227.05 $ | 400 $ | 172.95 % | 24/06/2024 |
| Paul Matteis | Stifel Nicolaus | 227.92 $ | 247 $ | 19.08 % | 24/06/2024 |
| Luca Issi | RBC Capital | 156.43 $ | 235 $ | 78.57 % | 12/06/2024 |
| Kostas Biliouris | BMO Capital | 156.59 $ | 234 $ | 77.41 % | 08/04/2024 |
| Edward Tenthoff | Piper Sandler | 229.37 $ | 253 $ | 23.63 % | 15/12/2022 |
| Olivia Brayer | Cantor Fitzgerald | 145.85 $ | 175 $ | 29.15 % | 12/07/2022 |
| Edward Tenthoff | Piper Sandler | 135.825 $ | 208 $ | 72.18 % | 14/06/2022 |
| Gary Nachman | BMO Capital | 150.76 $ | 175 $ | 24.24 % | 11/02/2022 |
| Zhiqiang Shu | Berenberg Bank | 150.76 $ | 154 $ | 3.24 % | 11/02/2022 |
| Luca Issi | RBC Capital | 150.86 $ | 225 $ | 74.14 % | 10/02/2022 |
| Debjit Chattopadhyay | Guggenheim | 142.51 $ | 170 $ | 27.49 % | 03/02/2022 |
| Tazeen Ahmad | Bank of America Securities | 130.12 $ | 209 $ | 78.88 % | 26/01/2022 |
| Maury Raycroft | Jefferies | 136.53 $ | 205 $ | 68.47 % | 23/01/2022 |
| Ritu Baral | Cowen & Co. | 186.42 $ | 250 $ | 63.58 % | 13/12/2021 |
| Salveen Richter | Goldman Sachs | 187.01 $ | 273 $ | 85.99 % | 22/11/2021 |
| Maneka Mirchandaney | Evercore ISI | 159.56 $ | 190 $ | 30.44 % | 29/10/2021 |
| Esther Rajavelu | UBS | 159.56 $ | 211 $ | 51.44 % | 29/10/2021 |
| Alethia Young | Cantor Fitzgerald | 159.56 $ | 275 $ | 115.44 % | 29/10/2021 |
| Gena Wang | Barclays | 162.14 $ | 210 $ | 47.86 % | 28/10/2021 |